Myricetin Increases Hepatic Peroxisome Proliferator-Activated Receptor α Protein Expression and Decreases Plasma Lipids and Adiposity in Rats
Figure 4
Representative immunoblots of protein expression of (a) PPARα, (b)ACO and CYP4A, and (c) SREBPs in livers of HFD-fed rats receiving 8-week treatment with myricetin (300 mg kg−1 per day) or fenofibrate (100 mg kg−1 per day). Rats not receiving any treatment were given the same volume of vehicle (distilled water) used to dissolve the test medications. Similar results were obtained with an additional 4 replications. Quantification of protein levels was expressed as mean with SEM ( per group) in each column. a compared to the values of vehicle-treated HFD-fed rats.
